China National Accord Medicines Corp Ltd (200028) - Total Assets
Based on the latest financial reports, China National Accord Medicines Corp Ltd (200028) holds total assets worth HK$49.12 Billion HKD (≈ $6.27 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check 200028 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
China National Accord Medicines Corp Ltd - Total Assets Trend (1992–2025)
This chart illustrates how China National Accord Medicines Corp Ltd's total assets have evolved over time, based on quarterly financial data. Explore 200028 long-term investments to assets to see how much of total assets are deployed in long-term investments.
China National Accord Medicines Corp Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
China National Accord Medicines Corp Ltd's total assets of HK$49.12 Billion consist of 81.9% current assets and 18.1% non-current assets.
| Asset Category | Amount (HKD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | HK$0.00 | 15.9% |
| Accounts Receivable | HK$21.54 Billion | 43.9% |
| Inventory | HK$8.12 Billion | 16.5% |
| Property, Plant & Equipment | HK$0.00 | 0.0% |
| Intangible Assets | HK$406.69 Million | 0.8% |
| Goodwill | HK$1.60 Billion | 3.3% |
Asset Composition Trend (1992–2025)
This chart illustrates how China National Accord Medicines Corp Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see China National Accord Medicines Corp Ltd (200028) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: China National Accord Medicines Corp Ltd's current assets represent 81.9% of total assets in 2025, an increase from 45.4% in 1992.
- Cash Position: Cash and equivalents constituted 15.9% of total assets in 2025, down from 33.9% in 1992.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 21.0% in 1992.
- Asset Diversification: The largest asset category is accounts receivable at 43.9% of total assets.
China National Accord Medicines Corp Ltd Competitors by Total Assets
Key competitors of China National Accord Medicines Corp Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sigma Healthcare Limited
F:S5YA
|
Germany | €1.83 Billion |
|
China National Medicines Corp Ltd
SHG:600511
|
China | CN¥35.13 Billion |
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$8.80 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$46.10 Million |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
China National Accord Medicines Corp Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.56 | 1.48 | 1.37 |
| Quick Ratio | 1.23 | 1.19 | 1.07 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | HK$14.41 Billion | HK$13.10 Billion | HK$8.93 Billion |
China National Accord Medicines Corp Ltd - Advanced Valuation Insights
This section examines the relationship between China National Accord Medicines Corp Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.36 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 3.2% |
| Total Assets | HK$49.10 Billion |
| Market Capitalization | $125.06 Million USD |
Valuation Analysis
Below Book Valuation: The market values China National Accord Medicines Corp Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: China National Accord Medicines Corp Ltd's assets grew by 3.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for China National Accord Medicines Corp Ltd (1992–2025)
The table below shows the annual total assets of China National Accord Medicines Corp Ltd from 1992 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | HK$49.10 Billion ≈ $6.27 Billion |
+3.24% |
| 2024-12-31 | HK$47.56 Billion ≈ $6.07 Billion |
-0.03% |
| 2023-12-31 | HK$47.57 Billion ≈ $6.07 Billion |
+11.63% |
| 2022-12-31 | HK$42.62 Billion ≈ $5.44 Billion |
-0.39% |
| 2021-12-31 | HK$42.78 Billion ≈ $5.46 Billion |
+8.05% |
| 2020-12-31 | HK$39.59 Billion ≈ $5.05 Billion |
+18.12% |
| 2019-12-31 | HK$33.52 Billion ≈ $4.28 Billion |
+15.87% |
| 2018-12-31 | HK$28.93 Billion ≈ $3.69 Billion |
+29.48% |
| 2017-12-31 | HK$22.34 Billion ≈ $2.85 Billion |
+4.84% |
| 2016-12-31 | HK$21.31 Billion ≈ $2.72 Billion |
+61.24% |
| 2015-12-31 | HK$13.22 Billion ≈ $1.69 Billion |
+3.04% |
| 2014-12-31 | HK$12.83 Billion ≈ $1.64 Billion |
+16.02% |
| 2013-12-31 | HK$11.06 Billion ≈ $1.41 Billion |
+18.96% |
| 2012-12-31 | HK$9.30 Billion ≈ $1.19 Billion |
+21.26% |
| 2011-12-31 | HK$7.67 Billion ≈ $978.56 Million |
+21.55% |
| 2010-12-31 | HK$6.31 Billion ≈ $805.09 Million |
+20.51% |
| 2009-12-31 | HK$5.23 Billion ≈ $668.08 Million |
+42.06% |
| 2008-12-31 | HK$3.68 Billion ≈ $470.27 Million |
+26.77% |
| 2007-12-31 | HK$2.91 Billion ≈ $370.97 Million |
+8.47% |
| 2006-12-31 | HK$2.68 Billion ≈ $342.02 Million |
+149.82% |
| 2005-12-31 | HK$1.07 Billion ≈ $136.90 Million |
+26.74% |
| 2004-12-31 | HK$846.19 Million ≈ $108.02 Million |
-16.08% |
| 2003-12-31 | HK$1.01 Billion ≈ $128.72 Million |
-4.21% |
| 2002-12-31 | HK$1.05 Billion ≈ $134.37 Million |
-5.86% |
| 2001-12-31 | HK$1.12 Billion ≈ $142.74 Million |
+127.79% |
| 2000-12-31 | HK$490.89 Million ≈ $62.66 Million |
-8.92% |
| 1999-12-31 | HK$538.95 Million ≈ $68.80 Million |
-4.16% |
| 1998-12-31 | HK$562.36 Million ≈ $71.79 Million |
+13.42% |
| 1997-12-31 | HK$495.82 Million ≈ $63.29 Million |
+11.02% |
| 1996-12-31 | HK$446.60 Million ≈ $57.01 Million |
+17.46% |
| 1995-12-31 | HK$380.21 Million ≈ $48.53 Million |
+0.12% |
| 1994-12-31 | HK$379.76 Million ≈ $48.48 Million |
-1.12% |
| 1993-12-31 | HK$384.07 Million ≈ $49.03 Million |
+103.29% |
| 1992-12-31 | HK$188.93 Million ≈ $24.12 Million |
-- |
About China National Accord Medicines Corp Ltd
China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers new and special drugs and medications for chronic diseases. It also provides traditional Chinese medicine, Western medicine, rehabilitation therapy, and various medical-related resources, as well as chemical drugs, OTC drugs, and healt… Read more